Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The first immunotherapy drug for any kind of lung cancer has been ... the proteins cancer can make to try and hide from the immune system," she said.
FDA Approves Nivolumab for the Treatment of Metastatic Squamous Non-small Cell Lung Cancer - Lung Disease News
In 2012 we had 1.6 million deaths worldwide from Lung Cancer. ... For most cancers the bodies immune system does not see the cancer cells as ...
So, how do once-lethal viruses hold the key to curing cancer? ... The re-energized immune system can then rid the body of the remnants of the ...
(Reuters) - CTI BioPharma Corp's experimental blood cancer drug ... to regulating the immune system and contributes to the growth of cancer cells.
It will also prevent the re-growth of cancer cells through metastasis. ... utilize the body's own immune system to fight cancer cells, or immuno-oncology.
Kaiser Permanente is enrolling lung cancer patients in two new clinical ... Funded by the National Cancer Institute, LUNG-MAP (Lung Cancer Master ... to a promising new drug that enhances the immune system, Kaiser officials said.
Prostate cancer is amenable to such therapeutic approaches. The improved understanding of the relationship between the immune system and ...
Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms - Abstract - UroToday
... new immunotechnology center designed to accelerate the development of new immunotherapy antibodies against cancer and inflammatory disease ...
EAGAN, Minn. — New preclinical research from Biothera further demonstrates the ability of its cancer immunotherapy drug candidate Imprime PGG® ...
"These new immunotherapies are potent treatment options that have ... Antibodies that block the PD-L1 pathway, which cancer cells use to hide from ...
... androgen-biosynthesis inhibitors, chemotherapy, immunotherapy and ... Metastatic castration-resistant prostate cancer (mCRPC) is a treatable yet ...
The Checkmate-017 trial was the first to show a cancer immunotherapy beat another oncology drug--in this case docetaxel--on overall survival stats.
Immunotherapy is a hot field in cancer research, as scientists try to figure out how to spur the body's own ability to fight tumours. The study is exciting, ...
Heat Biologics is examining candidate HS-410 in conjunction with standard treatment to stimulate the immune system and eliminate remaining cancer ...
JAK inhibitors work by disrupting the production of a protein that is key to regulating the immune system and contributes to the growth of cancer cells.
When it comes to the body's immune system and its response to cancerous cells, serial killer cells are the heroes of the day. Known as killer immune ...
Cancer and the #immune system are inextricably connected, and as you can learn from our new VideoAbstract featuring Alberto Mantovani from the ...
Bladder cancer is usually identified on the basis of visible blood in the urine or blood found on urine testing, but emergency admission is a common ...
“The decision underscores the unmet need for bladder cancer treatments and serves as an additional validation for our clinical program. Currently ...
(1888PressRelease) The Red Cross is a noble and respected institution that starts and is trying to solve the problem of cholera in Africa. But it must ...
Sandeep K. Reddy, Caris Life Sciences' representative said in a press release: “Prostate cancer and small cell bladder cancer present distinct sets of ...
The images in that citizen scientists see are really magnified samples of real head and neck, lung, and bladder cancer tumor tissue donated by former ...
Pancreatic cancer has a high mortality rate, mainly because of a lack of early symptoms and its aggressive migration nature. The patients are often ...
But not only are survival rates for lung cancer (a common type) and pancreatic cancer the worst in this table. They have also not improved as much as ...
For example, in pancreatic cancer, a new study recently published in the ... Fleshman, president and CEO of the Pancreatic Cancer Action Network.
TG01 targets cancer specific RAS mutations in pancreatic cancer. Today gemcitabine is the most frequently used standard of care chemotherapy for ...
Colliding federal policies are fomenting a nasty money war that's pitting community oncologists trying to treat patients in less expensive clinic settings against hospitals trying to woo patients in through costlier emergency departments.
Science Daily Cancer News
A protein called BAI1 involved in limiting the growth of brain tumors is also critical for spatial learning and memory, researchers have discovered. BAI1 is part of a regulatory network neuroscientists think is connected with autism spectrum disorders.
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States and is the country's fifth most common cause of cancer mortality in women. In 2015, it is estimated that more than 21,000 new diagnoses and more than 14,000 deaths from this neoplasm will occur in the United States; less than 40 percent of women with ovarian cancer are cured.
A researcher who has long examined quality-of-life issues in cancer patients wondered whether depression in African-American cancer patients has been under-recognized for treatment. Accurately assessing depression in cancer patients is difficult in general because the physical symptoms of cancer and depression -- low energy, lack of sleep and loss of appetite -- are so similar.
Eating a vegetarian diet was associated with a lower risk of colorectal cancers compared with nonvegetarians in a study of Seventh-Day Adventist men and women, according to a new article.
Another 15 genetic ‘hot-spots’ that can increase a woman’s risk of developing breast cancer have been discovered by researchers. This new discovery means that a total of more than 90 single nucleotide polymorphisms (SNPs) associated with breast cancer have now been revealed through research.
Lots of potentially useful medical information is getting lost. Researchers discovered this when they looked into the lack of reporting of information from “stalled drug” trials in cancer, cardiovascular and neurological diseases.
In an advance that could lead to better identification of malignant pediatric adrenocortical tumors, and ultimately to better treatment, researchers have mapped the “genomic landscape” of these rare childhood tumors. Their genomic mapping has revealed unprecedented details, not only of the aberrant genetic and chromosomal changes that drive the cancer, but the sequence of those changes that trigger it.
Lack of oxygen in cells is an indicator of diseases as serious as cerebral haemorrhages, stroke and cancer. Regrettably measuring real-time oxygen concentration in living tissue is difficult with current technologies. Now a chemist has invented a compound which measures oxygen in cells and other biological material with high precision. The compound is based on rare earths emitting colored light that vary in color with the amount of oxygen present in the sample. Because emissions are in the visible range of the spectrum, it will be possible to measure oxygen using the optical microscopes already present in most hospitals.
Breast cancer risk may be increased in women who have first-degree relatives with a history of prostate cancer
Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer.
Tambahkan Komentar